AI assistant
NORTHROP GRUMMAN CORP /DE/ — Director's Dealing 2018
Feb 15, 2018
29899_dirs_2018-02-15_134a47bb-eb75-4e04-8662-c9aa381480b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NORTHROP GRUMMAN CORP /DE/ (NOC)
CIK: 0001133421
Period of Report: 2018-02-13
Reporting Person: Hardesty Michael A (Corp VP, Controller & CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-13 | Common Stock | M | 3128.2800 | $0.0000 | Acquired | 12678.6400 | Direct |
| 2018-02-13 | Common Stock | F | 1097.0000 | $0.0000 | Disposed | 11581.6400 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-13 | Restricted Performance Stock Rights | $ | A | 2215.2800 | Acquired | Common Stock (2215.2800) | Direct | |
| 2018-02-13 | Restricted Performance Stock Rights | $ | M | 3128.2800 | Disposed | Common Stock (3128.2800) | Direct | |
| 2018-02-13 | Restricted Stock Rights | $ | A | 632.0000 | Acquired | Common Stock (632.0000) | Direct |
Footnotes
F1: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/18/15 with a valuation of performance measurement period ("measurement period") that ended 12/31/17. RPSRs to be settled at 131% of target. The shares are anticipated to be distributed into the participant's account on February 22, 2018.
F2: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e).
F3: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the application performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
F4: The RPSRs acquired include (i) 740.28 vested RPSRs with respect to the measurement period ended 12/31/17 acquired due to settlement of the 2015 RPSRs held at 131% of the target award and (ii) 1,475 unvested RPSRs granted under the LTISP on 2/13/18 with a measurement period ending on 12/31/20.
F5: Total amount includes 3,128.28 vested RPSRs granted under the LTISP on 2/18/15 with a measurement period ended on 12/31/17; 1,475 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; 1,786 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19; and 2,211 RPSRs granted on 2/17/16 with a measurement period ending on 12/31/18.
F6: Total amount includes 1,475 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; 1,786 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19; and 2,211 RPSRs granted on 2/17/16 with a measurement period ending on 12/31/18.
F7: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/13/18 and will vest on 2/13/21.
F8: Total amount includes 632 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; 765 RSRs granted under the LTISP on 2/17/17 that will vest on 2/17/20; 947 RSRs granted under the LTISP on 2/17/16 that will vest on 2/17/19; and 1,023 RSRs granted under the LTISP on 2/18/15 that will vest on 2/18/18.